Rocket Pharmaceuticals Ownership | Who Owns Rocket Pharmaceuticals?


OverviewForecastRevenueFinancialsChart

Rocket Pharmaceuticals Ownership Summary


Rocket Pharmaceuticals is owned by 98.29% institutional investors, 2.90% insiders. Rtw investments, lp is the largest institutional shareholder, holding 18.87% of RCKT shares. Vanguard Health Care Inv is the top mutual fund, with 7.13% of its assets in Rocket Pharmaceuticals shares.

RCKT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRocket Pharmaceuticals98.29%2.90%-1.19%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp17.69M18.87%$380.82M
Wellington management group llp9.16M9.77%$197.12M
Blackrock6.19M6.61%$133.33M
Vanguard group5.81M6.20%$125.06M
Westfield capital management co lp4.33M4.62%$93.18M
Maverick capital3.93M4.19%$84.58M
Price t rowe associates inc /md/3.17M3.38%$68.24M
Janus henderson group2.92M3.11%$62.84M
State street2.78M2.97%$59.85M
Franklin resources1.87M2.00%$40.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
M28 capital management lp385.68K10.76%$8.30M
Rtw investments, lp17.69M5.90%$380.82M
Acuta capital partners250.37K4.54%$5.39M
New leaf venture partners150.71K3.95%$3.24M
First turn management560.99K1.96%$12.08M
Boxer capital1.47M1.66%$31.56M
Tang capital management750.00K1.64%$16.15M
Maverick capital3.93M1.60%$84.58M
Frazier life sciences management1.56M1.57%$33.61M
Privium fund management b.v.250.98K1.27%$4.96M

Top Buyers

HolderShares% AssetsChange
Woodline partners lp561.97K0.12%561.97K
Vanguard group5.81M0.00%437.67K
Westfield capital management co lp4.33M0.46%343.89K
Janus henderson group2.92M0.03%313.06K
Invesco352.03K0.00%310.84K

Top Sellers

HolderShares% AssetsChange
State street2.78M0.00%-1.41M
Avoro capital advisors---1.26M
Logos global management lp350.00K0.61%-950.00K
Perceptive advisors1.25M0.64%-554.47K
Ecor1 capital---508.39K

New Positions

HolderShares% AssetsChangeValue
Woodline partners lp561.97K0.12%561.97K$12.10M
Mirae asset global etfs198.77K0.01%198.77K$4.28M
Corebridge financial35.40K0.00%35.40K$762.16K
Norges bank34.75K0.00%34.75K$748.21K
Marshall wace, llp19.58K0.00%19.58K$421.62K

Sold Out

HolderChange
Allspring global investments-20.00
Evermay wealth management-25.00
Innealta capital-49.00
Lazard asset management-78.00
Eversource wealth advisors-80.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241987.03%92,550,2191.43%981.04%97-2.02%5410.20%
Jun 30, 2024185-7.04%91,245,649-1.15%971.00%9911.24%49-23.44%
Mar 31, 2024199-4.78%92,305,1103.71%981.09%89-15.24%64-5.88%
Dec 31, 202320911.17%89,005,181-0.46%950.81%105-5.41%6854.55%
Sep 30, 202318812.57%89,420,74217.11%1081.20%11137.04%44-15.38%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Health Care Inv6.49M7.13%1.58M
RTW Biotech Opportunities Ord2.40M2.63%-
Vanguard Total Stock Mkt Idx Inv2.62M2.47%459.20K
SPDR® S&P Biotech ETF1.78M1.67%-20.79K
iShares Russell 2000 ETF1.77M1.67%-6.83K
Vanguard Institutional Extnd Mkt Idx Tr1.28M1.21%197.90K
Westfield Capital Mgt Co Sm-Cap Gr Eq1.21M1.14%206.89K
Harbor Small Cap Growth Instl1.21M1.14%182.00K
Vanguard Small Cap Index1.06M1.00%201.22K
US Small-Cap Growth II Equity Comp1.01M0.95%-867.00

Recent Insider Transactions


DateNameRoleActivityValue
Jan 23, 2025Militello John See RemarksSell$9.30K
Nov 21, 2024Militello John See RemarksSell$15.98K
Nov 21, 2024Patel Kinnari See RemarksSell$59.89K
Nov 21, 2024Shah Gaurav CEOSell$144.78K
Nov 21, 2024Wilson Martin General CounselSell$15.34K

Insider Transactions Trends


DateBuySell
2025 Q1-1
2024 Q3-6
2024 Q2-9
2024 Q1-9
2023 Q4-2

RCKT Ownership FAQ


Who Owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals shareholders are primarily institutional investors at 98.29%, followed by 2.90% insiders and -1.19% retail investors. The average institutional ownership in Rocket Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Rocket Pharmaceuticals falls below.

Who owns the most shares of Rocket Pharmaceuticals?

Rocket Pharmaceuticals’s largest shareholders are Rtw investments, lp (17.69M shares, 18.87%), Wellington management group llp (9.16M shares, 9.77%), and Blackrock (6.19M shares, 6.61%). Together, they hold 35.24% of Rocket Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rocket Pharmaceuticals?

Yes, BlackRock owns 6.61% of Rocket Pharmaceuticals, totaling 6.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 133.33M$. In the last quarter, BlackRock increased its holdings by 262.72K shares, a 4.43% change.

Who is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

M28 capital management lp is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.76% of its assets in 385.68K Rocket Pharmaceuticals shares, valued at 8.3M$.

Who is the top mutual fund holder of Rocket Pharmaceuticals shares?

Vanguard Health Care Inv is the top mutual fund holder of Rocket Pharmaceuticals shares, with 7.13% of its total shares outstanding invested in 6.49M Rocket Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools